Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$5.08 +0.34 (+7.17%)
At close: Sep 4, 2026 · 4:00 PM EDT

Orchestra BioMed Holdings (OBIO) Depreciation & Amortization - Total (2024 - 2025)

Analysis

Orchestra BioMed Holdings (OBIO) Depreciation & Amortization - Total (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Orchestra BioMed Holdings 322.25 Mn 127.72 Mn 63,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 81,000.00
Jun 30, 2025 81,000.00
Mar 31, 2025 83,000.00
Dec 31, 2024 84,000.00
Sep 30, 2024 76,000.00
Jun 30, 2024 74,000.00
Mar 31, 2024 74,000.00